mRNA Vaccines and Therapeutics Market Report

Global and Region mRNA Vaccines and Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：215
  • REPORT CODE：GMM1017038
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

    mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.

    The report details the trend, potential and market size of mRNA Vaccines and Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of mRNA Vaccines and Therapeuticsmarket, defines the market attractiveness level of mRNA Vaccines and Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of mRNA Vaccines and Therapeutics industry, describes the types of mRNA Vaccines and Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global mRNA Vaccines and Therapeutics market and the development prospects and opportunities of mRNA Vaccines and Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global mRNA Vaccines and Therapeutics market in Chapter 13.

    By Player:

    • BioNTech

    • eTheRNA

    • CureVac

    • Tiba Biotechnology

    • Sangamo Therapeutics

    • Argos Therapeutics

    • Ethris

    • Translate Bio

    • Moderna Therapeutics

    • In-Cell-Art

    By Type:

    • Standardization Of Cancer Treatment MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    By End-User:

    • Infectious Disease

    • Cancer

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 mRNA Vaccines and Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 mRNA Vaccines and Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 mRNA Vaccines and Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 mRNA Vaccines and Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise mRNA Vaccines and Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global mRNA Vaccines and Therapeutics Consumption (2017-2022)

    • 7.2 United States mRNA Vaccines and Therapeutics Consumption (2017-2022)

    • 7.3 Europe mRNA Vaccines and Therapeutics Consumption (2017-2022)

    • 7.4 China mRNA Vaccines and Therapeutics Consumption (2017-2022)

    • 7.5 Japan mRNA Vaccines and Therapeutics Consumption (2017-2022)

    • 7.6 India mRNA Vaccines and Therapeutics Consumption (2017-2022)

    • 7.7 South Korea mRNA Vaccines and Therapeutics Consumption (2017-2022)

    8 Region and Country-wise mRNA Vaccines and Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global mRNA Vaccines and Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States mRNA Vaccines and Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe mRNA Vaccines and Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China mRNA Vaccines and Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan mRNA Vaccines and Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India mRNA Vaccines and Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea mRNA Vaccines and Therapeutics Consumption Forecast (2022-2028)

    9 Global mRNA Vaccines and Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Standardization Of Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • 9.2 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Infectious Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global mRNA Vaccines and Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global mRNA Vaccines and Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Standardization Of Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global mRNA Vaccines and Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global mRNA Vaccines and Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global mRNA Vaccines and Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global mRNA Vaccines and Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 mRNA Vaccines and Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global mRNA Vaccines and Therapeutics Market Competitive Analysis

    • 14.1 BioNTech

      • 14.1.1 BioNTech Company Details

      • 14.1.2 BioNTech mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 BioNTech mRNA Vaccines and Therapeutics Product and Service

    • 14.2 eTheRNA

      • 14.2.1 eTheRNA Company Details

      • 14.2.2 eTheRNA mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 eTheRNA mRNA Vaccines and Therapeutics Product and Service

    • 14.3 CureVac

      • 14.3.1 CureVac Company Details

      • 14.3.2 CureVac mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 CureVac mRNA Vaccines and Therapeutics Product and Service

    • 14.4 Tiba Biotechnology

      • 14.4.1 Tiba Biotechnology Company Details

      • 14.4.2 Tiba Biotechnology mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Tiba Biotechnology mRNA Vaccines and Therapeutics Product and Service

    • 14.5 Sangamo Therapeutics

      • 14.5.1 Sangamo Therapeutics Company Details

      • 14.5.2 Sangamo Therapeutics mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product and Service

    • 14.6 Argos Therapeutics

      • 14.6.1 Argos Therapeutics Company Details

      • 14.6.2 Argos Therapeutics mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Argos Therapeutics mRNA Vaccines and Therapeutics Product and Service

    • 14.7 Ethris

      • 14.7.1 Ethris Company Details

      • 14.7.2 Ethris mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Ethris mRNA Vaccines and Therapeutics Product and Service

    • 14.8 Translate Bio

      • 14.8.1 Translate Bio Company Details

      • 14.8.2 Translate Bio mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Translate Bio mRNA Vaccines and Therapeutics Product and Service

    • 14.9 Moderna Therapeutics

      • 14.9.1 Moderna Therapeutics Company Details

      • 14.9.2 Moderna Therapeutics mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Moderna Therapeutics mRNA Vaccines and Therapeutics Product and Service

    • 14.10 In-Cell-Art

      • 14.10.1 In-Cell-Art Company Details

      • 14.10.2 In-Cell-Art mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 In-Cell-Art mRNA Vaccines and Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of mRNA Vaccines and Therapeutics

    • Figure mRNA Vaccines and Therapeutics Picture

    • Table Global mRNA Vaccines and Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global mRNA Vaccines and Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global mRNA Vaccines and Therapeutics Consumption by Country (2017-2022)

    • Figure United States mRNA Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe mRNA Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China mRNA Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan mRNA Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India mRNA Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea mRNA Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global mRNA Vaccines and Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States mRNA Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe mRNA Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China mRNA Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan mRNA Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India mRNA Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea mRNA Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Standardization Of Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Standardization Of Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global mRNA Vaccines and Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global mRNA Vaccines and Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table BioNTech (Foundation Year, Company Profile and etc.)

    • Table BioNTech mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioNTech mRNA Vaccines and Therapeutics Product and Service

    • Table eTheRNA (Foundation Year, Company Profile and etc.)

    • Table eTheRNA mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table eTheRNA mRNA Vaccines and Therapeutics Product and Service

    • Table CureVac (Foundation Year, Company Profile and etc.)

    • Table CureVac mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table CureVac mRNA Vaccines and Therapeutics Product and Service

    • Table Tiba Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Tiba Biotechnology mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiba Biotechnology mRNA Vaccines and Therapeutics Product and Service

    • Table Sangamo Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Sangamo Therapeutics mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo Therapeutics mRNA Vaccines and Therapeutics Product and Service

    • Table Argos Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Argos Therapeutics mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Argos Therapeutics mRNA Vaccines and Therapeutics Product and Service

    • Table Ethris (Foundation Year, Company Profile and etc.)

    • Table Ethris mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ethris mRNA Vaccines and Therapeutics Product and Service

    • Table Translate Bio (Foundation Year, Company Profile and etc.)

    • Table Translate Bio mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Translate Bio mRNA Vaccines and Therapeutics Product and Service

    • Table Moderna Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Moderna Therapeutics mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moderna Therapeutics mRNA Vaccines and Therapeutics Product and Service

    • Table In-Cell-Art (Foundation Year, Company Profile and etc.)

    • Table In-Cell-Art mRNA Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table In-Cell-Art mRNA Vaccines and Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US